Patent · US Active

Polymorphs of 5-fluoro-4-imino-3-methyl-1 -tosyl-3,4-dihydropyrimidin-2-one

US11632954B2 · kind B2 · utility

1Cited by
38References
39Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 16, 2018
Grant dateApr 25, 2023
Priority date
Expiry dateJul 16, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present subject matter provides a crystalline form of the compound having the following structure: wherein the crystalline form is a polymorph, hydrate or solvate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.